tykhr
sign in
free sign up
Neurocrine Biosciences Inc
Drug Manufacturers - Specialty & Generic
Healthcare
NBIX
103 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
146.00
52 week high
153.29
high
147.56
52 week low
0.00
low
145.67
growth
23.70 %
previous Close
146.62
P/E ratio
market cap
12.41 B
div yield
0
usd
Mar 2025
qoq
revenue
573 M
-8.78 %
net incoming
7.90 M
-92.34 %
eps
0.00 %
-58.58 %
eps surprise
-36.02 %
net profit margin
1.38 %
-15.00 %
operating incoming
23.60 M
-83.38 %
net change in cash
-38.90 M
66.49 %
cash on hand
194 M
-16.70 %
cost of revenue
9.20 M
-1.08 %
top